Revalesio has adopted a diversified development strategy with product candidates in multiple therapeutic categories. Our pipeline features products in various stages of development, from discovery stage explorations to proof of concept clinical trials and reflects the diversity of conditions we believe can be effectively treated with charge-stablized nanostructure products.